Neha Patel
speaker
24 appearances
1 recordings
1 series
first heard Jul 2019
last heard Jul 2019
Neha Patel’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
McKinsey on Healthcare, a podcast series about visionaries, leaders, and problem solvers shaping the future of healthcare.
On today's episode, McKinsey partner Neha Patel is joined by Ron Kovetz.
We'd love to hear a bit about your perspectives on the dynamics in the physician industry.
In particular, what are some of the near and long-term implications of ongoing and escalating consolidation of the sector by both hospitals and private equity of primary care physicians?
What impact do you think that will have on various players in the industry?
Shifting gears a bit, we'd love to hear the view from the physicians.
So with all the new sources of administrative work that's required of them, what is a value proposition for them to work with various aggregators in the industry?
And what do you think is the role of technology, such as automation, in improving physician productivity and some of the issues that you raised?
And what do you think are the key enablers to unlocking this?
Many folks have acknowledged that risk is difficult and there is variability of success in shared savings programs.
In your mind, is risk working?
And have you seen physicians really change their behavior as a result of risk-taking?
Do you think that there's any components of taking on risks that have become commoditized?
And where do you believe that physicians will differentiate in the future?
When we think about where the landscape could go, I would love your perspectives on what are the market characteristics that make a new geography attractive to a risk-taking player or one that wants to play in the market?
Do you think that PPO concentrated markets matter at all and how does the physician aggregation model actually fit there?
Well, we know there's a lot of value proposition behind Medicare Advantage, but is there one behind Medicaid?
Or is there too little evidence today to prove the value given the profitability issue?
You called out a couple of things, pharmacy, behavioral, different factors that are different for these patients potentially.
What do you think are the most important capabilities that will be required to manage this population looking forward?
Showing 1–20 of 24 · page 1 of 2
Next →